151 related articles for article (PubMed ID: 20002888)
1. The PGF(2alpha) receptor FP is lost in nevi and melanoma.
Fricke A; McClelland L; Scott G
Pigment Cell Melanoma Res; 2010 Feb; 23(1):141-3. PubMed ID: 20002888
[No Abstract] [Full Text] [Related]
2. Pigment transformation and induction in hamster malignant amelanotic melanocytes. An effect of nucleic acids from hamster benign blue nevus.
Lipkin G
J Invest Dermatol; 1971 Jul; 57(1):49-65. PubMed ID: 5556532
[No Abstract] [Full Text] [Related]
3. Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study.
Loir B; Pérez Sánchez C; Ghanem G; Lozano JA; García-Borrón JC; Jiménez-Cervantes C
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1083-92. PubMed ID: 10644013
[TBL] [Abstract][Full Text] [Related]
4. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
8. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
9. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tubulin β-3 as a novel senescence-associated gene in melanocytic malignant transformation.
Orfanidis K; Wäster P; Lundmark K; Rosdahl I; Öllinger K
Pigment Cell Melanoma Res; 2017 Mar; 30(2):243-254. PubMed ID: 28024114
[TBL] [Abstract][Full Text] [Related]
11. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
12. Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Sharma BK; Smith CC; Laing JM; Rucker DA; Burnett JW; Aurelian L
Dermatology; 2006; 213(3):192-9. PubMed ID: 17033167
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
14. p15 Expression Differentiates Nevus from Melanoma.
Taylor LA; O'Day C; Dentchev T; Hood K; Chu EY; Ridky TW; Seykora JT
Am J Pathol; 2016 Dec; 186(12):3094-3099. PubMed ID: 27855847
[TBL] [Abstract][Full Text] [Related]
15. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.
Collins KA; White WL
Am J Dermatopathol; 1995 Oct; 17(5):429-38. PubMed ID: 8599446
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of germinal center-associated nuclear protein (GANP) is associated with malignant transformation of melanocytes.
Kageshita T; Kuwahara K; Oka M; Ma D; Ono T; Sakaguchi N
J Dermatol Sci; 2006 Apr; 42(1):55-63. PubMed ID: 16431081
[TBL] [Abstract][Full Text] [Related]
18. Frequent downregulation of Fas (CD95) expression and function in melanoma.
Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE
Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
Spanjaard RA; Whren KM; Graves C; Bhawan J
Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.
Huang JM; Chikeka I; Hornyak TJ
Dermatol Clin; 2017 Jan; 35(1):85-93. PubMed ID: 27890240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]